Common Contracts

FIRST AMENDMENT OF CLINICAL CLINICAL INVESTIGATION AGREEMENT FOR THE DRUGS

Clinical Investigation Agreement • August 17th, 2022

• Contract Type
  Clinical Investigation Agreement
• Filed
  August 17th, 2022

– 20128 Torino (Italy) (hereinafter “Entity”) and University of Turin, Department of Biological and Clinical Sciences (hereinafter the “University”) with registered office in Turin, Via Verdi 8 and administrative office in Orbassano, Regione Gonzole 10, Italy, and Gilead Sciences, Inc., having its principal address at 333 Lakeside Drive, Foster City, California 94404 (together with its affiliates and subsidiaries “Gilead” (hereinafter the “Sponsor”). Capitalized terms used herein but not defined herein will have the meanings ascribed to such terms in the Agreement. Entity, University and Gilead are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”